loadpatents
name:-0.044400930404663
name:-0.011638164520264
name:-0.0013730525970459
Maneval; Daniel C. Patent Filings

Maneval; Daniel C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Maneval; Daniel C..The latest application filed is for "combination therapy with an anti-hyaluronan agent and therapeutic agent".

Company Profile
1.11.40
  • Maneval; Daniel C. - San Diego CA
  • Maneval; Daniel C. - Carlsbad CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Combination Therapy With An Anti-hyaluronan Agent And Therapeutic Agent
App 20190083449 - Maneval; Daniel C. ;   et al.
2019-03-21
Combination therapy with an anti-hyaluronan agent and therapeutic agent
Grant 10,137,104 - Maneval , et al. November 27, 2
2018-11-27
Combination therapy with an anti-hyaluronan agent and therapeutic agent
Grant 9,913,822 - Maneval , et al. March 13, 2
2018-03-13
Combination Therapy With An Anti-hyaluronan Agent And Therapeutic Agent
App 20170290796 - Maneval; Daniel C. ;   et al.
2017-10-12
Combination therapy with an anti-hyaluronan agent and therapeutic agent
App 20130302400 - Maneval; Daniel C. ;   et al.
2013-11-14
Compositions And Methods For Therapeutic Use
App 20110104118 - Engler; Heidrun ;   et al.
2011-05-05
Recombinant Adenoviral Vectors And Methods Of Use
App 20090088398 - Gregory; Richard J. ;   et al.
2009-04-02
Adenoviral vectors having a protein IX deletion
App 20090082289 - Gregory; Richard J. ;   et al.
2009-03-26
Compositions And Methods For Therapeutic Use
App 20090048148 - Engler; Heidrun ;   et al.
2009-02-19
Nucleic acid delivery
Grant 7,462,351 - Conroy , et al. December 9, 2
2008-12-09
Adenoviral vectors having a protein IX deletion
App 20080299083 - Gregory; Richard J. ;   et al.
2008-12-04
Combined Tumor Suppressor Gene Therapy And Chemotherapy In The Treatment Of Neoplasms
App 20080286239 - Nielsen; Loretta ;   et al.
2008-11-20
Adenoviral vectors having a protein IX deletion
App 20080182807 - Gregory; Richard J. ;   et al.
2008-07-31
Adenoviral Vectors Having A Protein Ix Deletion
App 20080175818 - Gregory; Richard J. ;   et al.
2008-07-24
Adenoviral vectors having a protein IX deletion
App 20070259429 - Gregory; Richard J. ;   et al.
2007-11-08
Recombinant Adenoviral Vectors And Methods Of Use
App 20070253932 - Gregory; Richard J. ;   et al.
2007-11-01
Adenoviral vectors having a protein IX deletion
App 20070128166 - Gregory; Richard J. ;   et al.
2007-06-07
Combined Tumor Suppressor Gene Therapy And Chemotherapy In The Treatment Of Neoplasms
App 20070122379 - Nielsen; Loretta ;   et al.
2007-05-31
Recombinant adenoviral vector and method of use
App 20070031381 - Gregory; Richard J. ;   et al.
2007-02-08
Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
App 20070014768 - Nielson; Loretta ;   et al.
2007-01-18
Nucleic acid delivery
App 20070009485 - Conroy; Susan E. ;   et al.
2007-01-11
Adenoviral vectors having a protein IX deletion
App 20070009486 - Gregory; Richard J. ;   et al.
2007-01-11
Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
Grant 7,157,079 - Nielsen , et al. January 2, 2
2007-01-02
Adenoviral vectors having a protein IX deletion
App 20060275261 - Gregory; Richard J. ;   et al.
2006-12-07
Adenoviral vectors having a protein IX deletion
App 20060233759 - Gregory; Richard J. ;   et al.
2006-10-19
Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells
Grant 7,105,156 - Lee , et al. September 12, 2
2006-09-12
Nucleic acid delivery
Grant 7,094,583 - Conroy , et al. August 22, 2
2006-08-22
Adenoviral vectors having a protein IX deletion
App 20060171925 - Gregory; Richard J. ;   et al.
2006-08-03
Recombinant adenoviral vectors and methods of use
App 20060140910 - Gregory; Richard J. ;   et al.
2006-06-29
Adenoviral vectors having a protein IX deletion
App 20060099187 - Gregory; Richard J. ;   et al.
2006-05-11
Recombinant adenoviral vector and method of use
Grant 7,041,284 - Gregory , et al. May 9, 2
2006-05-09
Adenoviral vectors having a protein IX deletion
App 20060039893 - Gregory; Richard J. ;   et al.
2006-02-23
Adenoviral vectors having a protein IX deletion
App 20060034804 - Gregory; Richard J. ;   et al.
2006-02-16
Recombinant adenoviral vector and methods of use
Grant 6,989,268 - Gregory , et al. January 24, 2
2006-01-24
Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
App 20050142112 - Nielsen, Loretta ;   et al.
2005-06-30
Nucleic acid delivery
App 20050014259 - Conroy, Susan E. ;   et al.
2005-01-20
Adenoviral vectors having a protein IX deletion
App 20040266006 - Gregory, Richard J. ;   et al.
2004-12-30
Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
App 20040235736 - Nielsen, Loretta ;   et al.
2004-11-25
Recombinant adenoviral vector and methods of use
App 20040087027 - Gregory, Richard J. ;   et al.
2004-05-06
Recombinant adenoviral vector and methods of use
App 20040038404 - Gregory, Richard J. ;   et al.
2004-02-26
Compositions and methods for therapeutic use
App 20030211598 - Engler, Heidrun ;   et al.
2003-11-13
Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
App 20030064949 - Nielsen, Loretta ;   et al.
2003-04-03
Combined Tumor Suppressor Gene Therapy And Chemotherapy In The Treatment Of Neoplasms
App 20030060434 - NIELSEN, LORETTA ;   et al.
2003-03-27
Adenoviral vectors having a protein IX deletion
App 20020137212 - Gregory, Richard J. ;   et al.
2002-09-26
Nucleic acid delivery
App 20020081736 - Conroy, Susan E. ;   et al.
2002-06-27
Recombinant Adenoviral Vector And Method Of Use
App 20010016192 - GREGORY, RICHARD J. ;   et al.
2001-08-23
Recombinant Adenoviral Vector And Methods Of Use
App 20010006629 - GREGORY, RICHARD J. ;   et al.
2001-07-05
Recombinant adenoviral vector and methods of use
Grant 6,210,939 - Gregory , et al. April 3, 2
2001-04-03
Compositions and methods for therapeutic use
Grant 6,165,779 - Engler , et al. December 26, 2
2000-12-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed